Travere Therapeutics Inc (NAS:TVTX)
$ 6.42 -0.14 (-2.13%) Market Cap: 488.75 Mil Enterprise Value: 463.14 Mil PE Ratio: 0 PB Ratio: 6.62 GF Score: 58/100

Q4 2020 Travere Therapeutics Inc Earnings Call Transcript

Mar 01, 2021 / 09:30PM GMT
Release Date Price: $30.56 (-0.84%)
Operator

Good afternoon, ladies and gentlemen, and welcome to Travere Therapeutics Fourth Quarter and Full Year 2020 Financial Results and Corporate Update. (Operator Instructions) As a reminder, this conference call is being recorded.

I would now like to turn the conference over to your host, Mr. Chris Cline. Thank you. Please go ahead, sir.

Chris Cline
Travere Therapeutics, Inc. - SVP of IR & Corporate Communications

Thank you, Katrina. Good afternoon, and welcome to Travere Therapeutics Fourth Quarter and Full Year 2020 Financial Results and Corporate Update Call. Thank you for joining us. I hope you all remain well.

Today's call will be led by our Chief Executive Officer, Dr. Eric Dube. Eric will be joined for the prepared remarks by our Chief Medical Officer, Dr. Noah Rosenberg; Peter Heerma, our Chief Commercial Officer; and our Chief Financial Officer, Laura Clague. Dr. Bill Rote, Senior Vice President of Research and Development, will join us for the Q&A session.

Before we begin, I'd like to remind everyone that statements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot